Conmed (CNMD) Tops Q2 EPS by 7c, provides guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $51.13 -0.7%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
MOV, SJM, LITB, More
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
MOV, SJM, LITB, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q2 EPS of $0.98, $0.07 better than the analyst estimate of $0.91. Revenue for the quarter came in at $332.1 million versus the consensus estimate of $334.34 million.
GUIDANCE:
Conmed sees FY 2024 EPS of $3.95-$4.02, versus the consensus of $4.29. Conmed sees FY 2024 revenue of $1.305-1.315 billion, versus the consensus of $1.34 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Zoom (ZM) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
